Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Orally disintegrating tablet of meloxicam and its preparation

An orally disintegrating tablet and meloxicam technology is applied in the directions of pharmaceutical formulations, medical preparations containing active ingredients, and pill delivery. In the mouth, affecting the elderly and children at night, etc., to achieve the effect of less adverse reactions, alleviation of gastrointestinal discomfort, and convenient taking

Active Publication Date: 2005-12-28
CHENGDU SHENGNUO BIOTEC CO LTD
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, although meloxicam has various oral dosage forms, it is not very convenient for the elderly and children who have difficulty swallowing
For example: In the case of tablets and capsules commonly used as oral preparations, many elderly people and children with poor swallowing ability are reluctant to take these solid dosage forms, complaining of difficulty swallowing medicine or esophageal obstruction, while chewable tablets are also It is also not suitable for the elderly and children with weak chewing ability
As far as powders or granules are concerned, in addition to their difficulty in swallowing, they are also easy to stay in the mouth, resulting in an unpleasant feeling in the mouth. At the same time, drinking water is required when taking the above oral preparations, especially the elderly and children need to take a lot of water However, drinking too much water will affect the night rest of the elderly and children
Syrups are considered an ideal dosage form for the elderly and children, but for many elderly and infirm patients who are still unable to deliver liquid preparations into their own mouths, these dosage forms cannot be considered suitable for the elderly and infirm due to the difficulties in taking the medication. The most suitable dosage form for children
In addition, the bitter taste and bad smell of many oral medicines are often unacceptable, causing some patients to refuse treatment in order to avoid taking the medicine, delaying the best time for treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Orally disintegrating tablet of meloxicam and its preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] The oral disintegrating tablet of meloxicam comprises a main drug and auxiliary materials, and is characterized in that it is prepared according to the following weight percentages: 7.5% of the main drug and 92.5% of the auxiliary materials.

[0043] The orally disintegrating tablet of the present invention is prepared from the following raw materials by weight:

[0044] Meloxicam 7.5g

[0045] Lactose 44.0g

[0046] Mannitol 16.0g

[0047] Microcrystalline Cellulose 21.1g

[0048] Low Substituted Hydroxypropyl Cellulose 2.4g

[0049] Cross-linked polyvinylpyrrolidone 5.0g

[0050] Sodium Bicarbonate 1.0g

[0051] Citric acid 1.0g

[0052] Aspartame 0.5g

[0053] Peppermint Flavor 0.5g

[0054] Magnesium Stearate 1.0g

[0055] A total of 1000 tablets were made

[0056] Among them, lactose and mannitol are fillers. Low-substituted hydroxypropyl cellulose, microcrystalline cellulose and cross-linked polyvinylpyrrolidone are disintegrants. Citric acid and sodiu...

Embodiment 2

[0065]The oral disintegrating tablet of meloxicam comprises a main drug and auxiliary materials, and is characterized in that it is prepared according to the following weight percentages: 15% of the main drug and 85% of the auxiliary materials.

[0066] The orally disintegrating tablet of the present invention is prepared from the following raw materials by weight:

[0067] Meloxicam 15.0g

[0068] Lactose 40.0g

[0069] Mannitol 20.0g

[0070] Microcrystalline Cellulose 20.0g

[0071] Low Substituted Hydroxypropyl Cellulose 4.0g

[0072] Cross-linked polyvinylpyrrolidone 5.0g

[0073] Sodium Bicarbonate 1.0g

[0074] Citric acid 1.0g

[0075] Aspartame 0.5g

[0076] Peppermint Flavor 0.5g

[0077] Magnesium Stearate 1.0g

[0078] A total of 1000 tablets were made

[0079] Among them, lactose and mannitol are fillers. Low-substituted hydroxypropyl cellulose, microcrystalline cellulose and cross-linked polyvinylpyrrolidone are disintegrants. Citric acid and sodium b...

Embodiment 3

[0090] The oral disintegrating tablet of meloxicam comprises a main drug and auxiliary materials, and is characterized in that it is prepared according to the following weight percentages: 3% of the main drug and 97% of the auxiliary materials.

[0091] The orally disintegrating tablet of the present invention is prepared from the following raw materials by weight:

[0092] Meloxicam 3.0g

[0093] Lactose 48.0g

[0094] Mannitol 10.0g

[0095] Microcrystalline Cellulose 15.0g

[0096] Low Substituted Hydroxypropyl Cellulose 10.0g

[0097] Cross-linked polyvinylpyrrolidone 3.0g

[0098] Sodium Bicarbonate 5.0g

[0099] Citric acid 5.0g

[0100] Aspartame 1.0g

[0101] Peppermint Flavor 0.15g

[0102] Cherry Flavor 0.85g

[0103] Magnesium Stearate 0.Sg

[0104] A total of 1000 tablets were made

[0105] Among them, lactose and mannitol are fillers. Low-substituted hydroxypropyl cellulose, microcrystalline cellulose and cross-linked polyvinylpyrrolidone are disintegr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
hardnessaaaaaaaaaa
hardnessaaaaaaaaaa
hardnessaaaaaaaaaa
Login to View More

Abstract

The invention discloses a meloxicam orally disintegrating tablet. The main drug is meloxicam, and the auxiliary materials include lactose, mannitol, microcrystalline cellulose, low-substituted hydroxypropyl cellulose, cross-linked polyvinylpyrrolidone, Sodium bicarbonate, citric acid, aspartame, essence, magnesium stearate, the present invention has good therapeutic effect to rheumatoid arthritis, painful osteoarthritis, and convenient to take, can disintegrate rapidly, give some It provides convenience for the elderly, infants and children, or those who have difficulty swallowing medicines, or patients who have trouble getting water.

Description

Technical field: [0001] The invention relates to an oral pharmaceutical preparation for treating rheumatoid arthritis and painful osteoarthritis and a preparation method thereof, in particular to a meloxicam orally disintegrating tablet that can rapidly disintegrate, release and mask bad taste and its preparation method. Background technique: [0002] In the prior art, clinical studies have shown that meloxicam has strong anti-inflammatory activity, better gastrointestinal and renal tolerance than other NSAIDS, and can effectively treat rheumatoid arthritis (RA) and osteoarthritis. Arthritis (OA). [0003] At present, although meloxicam is available in various oral dosage forms, it is not very convenient for the elderly and children who have some difficulty swallowing. For example: In the case of tablets and capsules that are commonly used in oral formulations, many elderly and children with poor swallowing abilities are reluctant to take these solid dosage forms and compl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/20A61K31/5415A61P19/02A61P29/00
Inventor 谢期林谢海峰马进
Owner CHENGDU SHENGNUO BIOTEC CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products